Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-16-000784
Filing Date
2016-04-13
Accepted
2016-04-12 18:19:14
Documents
49
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q entb022916form10q.htm 10-Q 290464
8 EXHIBIT 31.1 ex31_1.htm EX-31.1 10289
9 EXHIBIT 31.2 ex31_2.htm EX-31.2 10143
10 EXHIBIT 32.1 ex32_1.htm EX-32.1 6489
11 EXHIBIT 32.2 ex32_2.htm EX-32.2 6499
  Complete submission text file 0001607062-16-000784.txt   1567171

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE entb-20160229.xml EX-101.INS 169160
3 XBRL SCHEMA FILE entb-20160229.xsd EX-101.SCH 22458
4 XBRL CALCULATION FILE entb-20160229_cal.xml EX-101.CAL 21417
5 XBRL DEFINITION FILE entb-20160229_def.xml EX-101.DEF 67787
6 XBRL LABEL FILE entb-20160229_lab.xml EX-101.LAB 125819
7 XBRL PRESENTATION FILE entb-20160229_pre.xml EX-101.PRE 119295
Mailing Address 4700 SPRING STREET, ST 304 LA MESA CA 91941
Business Address 4700 SPRING STREET, ST 304 LA MESA CA 91941 (619) 330-2328
ENTEST BIOMEDICAL, INC. (Filer) CIK: 0001449447 (see all company filings)

EIN.: 263431263 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-154989 | Film No.: 161568100
SIC: 2834 Pharmaceutical Preparations